Selective inhibition of vaccinia virus by the antibiotic rifampicin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D001769:Blood; D046508:Culture Techniques; D003864:Depression, Chemical; D004622:Embryo, Mammalian / Q000166:cytology; D004625:Embryo, Nonmammalian; D011213:Poxviridae Infections / Q000188:drug therapy; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D012293:Rifampin; D013302:Streptomyces; D014616:Vaccinia virus / Q000187:drug effects* / Q000302:isolation & purification; D014721:Vesicular stomatitis Indiana virus / Q000302:isolation & purification; D014776:Virus Cultivation; D014779:Virus Replication / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D012316:RNA Nucleotidyltransferases; D012293:Rifampin